[
  {
    "ts": null,
    "headline": "Moderna, Inc. (MRNA) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript",
    "summary": "Moderna, Inc. (MRNA) Piper Sandler 37th Annual Healthcare Conference December 2, 2025 11:00 AM ESTCompany ParticipantsJames Mock - Chief Financial...",
    "url": "https://finnhub.io/api/news?id=addf31f11987f296af320ebf823771febf702bc503f2b48016965c5278bf1f2f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764682409,
      "headline": "Moderna, Inc. (MRNA) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript",
      "id": 137664355,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Moderna, Inc. (MRNA) Piper Sandler 37th Annual Healthcare Conference December 2, 2025 11:00 AM ESTCompany ParticipantsJames Mock - Chief Financial...",
      "url": "https://finnhub.io/api/news?id=addf31f11987f296af320ebf823771febf702bc503f2b48016965c5278bf1f2f"
    }
  },
  {
    "ts": null,
    "headline": "Vaccine stocks brace for shock waves at this week’s ACIP meeting",
    "summary": "Investing.com -- Bernstein warned in a note Tuesday that “shock waves are expected at the ACIP meeting this week,” citing a series of unusual developments that could have implications for Merck, Pfizer and Moderna.",
    "url": "https://finnhub.io/api/news?id=9df4e5df0f6ad295e04cf666ad129b80b9c1de065ee2482c4456ccb42e98f79e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764681144,
      "headline": "Vaccine stocks brace for shock waves at this week’s ACIP meeting",
      "id": 137662243,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Investing.com -- Bernstein warned in a note Tuesday that “shock waves are expected at the ACIP meeting this week,” citing a series of unusual developments that could have implications for Merck, Pfizer and Moderna.",
      "url": "https://finnhub.io/api/news?id=9df4e5df0f6ad295e04cf666ad129b80b9c1de065ee2482c4456ccb42e98f79e"
    }
  },
  {
    "ts": null,
    "headline": "Eikon Therapeutics Announces the Election of David W. Meline to its Board of Directors",
    "summary": "MILLBRAE, Calif., December 02, 2025--Eikon Therapeutics, Inc., a late-stage clinical biopharmaceutical company dedicated to integrating advanced engineering with cutting-edge research to accelerate drug discovery, today announced the election of David W. Meline as an independent director effective November 23, 2025. Mr. Meline is the former Chief Financial Officer at Moderna Inc.",
    "url": "https://finnhub.io/api/news?id=1eb9ed06174f786b4560127d1279a45d4688c291bfefa8321d3af771a3a628c7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764680400,
      "headline": "Eikon Therapeutics Announces the Election of David W. Meline to its Board of Directors",
      "id": 137662273,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "MILLBRAE, Calif., December 02, 2025--Eikon Therapeutics, Inc., a late-stage clinical biopharmaceutical company dedicated to integrating advanced engineering with cutting-edge research to accelerate drug discovery, today announced the election of David W. Meline as an independent director effective November 23, 2025. Mr. Meline is the former Chief Financial Officer at Moderna Inc.",
      "url": "https://finnhub.io/api/news?id=1eb9ed06174f786b4560127d1279a45d4688c291bfefa8321d3af771a3a628c7"
    }
  },
  {
    "ts": null,
    "headline": "Company News for Dec 2, 2025",
    "summary": "Companies In The Article Are: SNPS,DIS,CPNG,MRNA",
    "url": "https://finnhub.io/api/news?id=6b8106e71b555909d39246597ab8898d734cbd68a41cc30cf2f4269f9a70d9a6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764679980,
      "headline": "Company News for Dec 2, 2025",
      "id": 137662065,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Companies In The Article Are: SNPS,DIS,CPNG,MRNA",
      "url": "https://finnhub.io/api/news?id=6b8106e71b555909d39246597ab8898d734cbd68a41cc30cf2f4269f9a70d9a6"
    }
  },
  {
    "ts": null,
    "headline": "Stock Index Futures Gain as Investors Recover Risk Appetite",
    "summary": "December S&P 500 E-Mini futures (ESZ25) are up +0.27%, and December Nasdaq 100 E-Mini futures (NQZ25) are up +0.39% this morning, signaling a rebound from yesterday’s sell-off on Wall Street as investor risk appetite gradually returns at the start of December, a period that has historically been strong for markets.",
    "url": "https://finnhub.io/api/news?id=d321288b2c362d240be97ed2c8c7d23e95a5f2591deb59308560ce1dd47d2272",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764674570,
      "headline": "Stock Index Futures Gain as Investors Recover Risk Appetite",
      "id": 137662332,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "December S&P 500 E-Mini futures (ESZ25) are up +0.27%, and December Nasdaq 100 E-Mini futures (NQZ25) are up +0.39% this morning, signaling a rebound from yesterday’s sell-off on Wall Street as investor risk appetite gradually returns at the start of December, a period that has historically been strong for markets.",
      "url": "https://finnhub.io/api/news?id=d321288b2c362d240be97ed2c8c7d23e95a5f2591deb59308560ce1dd47d2272"
    }
  },
  {
    "ts": null,
    "headline": "Is Moderna Stock Underperforming the Nasdaq?",
    "summary": "Moderna has continued to underperform the Nasdaq Composite over the past year, and analysts remain cautious about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=333e4a85a4a223300434966b45c4ca54720ea30e4c1bbb97d7afc56eb49d4ce9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764667055,
      "headline": "Is Moderna Stock Underperforming the Nasdaq?",
      "id": 137662590,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna has continued to underperform the Nasdaq Composite over the past year, and analysts remain cautious about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=333e4a85a4a223300434966b45c4ca54720ea30e4c1bbb97d7afc56eb49d4ce9"
    }
  },
  {
    "ts": null,
    "headline": "Tougher FDA Rules on Vaccine Approval Might Change the Case for Investing in Moderna (MRNA)",
    "summary": "Moderna recently faced pressure after the U.S. Food and Drug Administration announced plans to require more rigorous safety and efficacy evidence for vaccine approvals, following reports of child fatalities linked to COVID-19 vaccinations. This regulatory overhaul is expected to increase development hurdles for vaccine makers, posing significant new challenges for Moderna’s ongoing innovation and pipeline expansion. We’ll explore how heightened regulatory scrutiny could shape Moderna’s...",
    "url": "https://finnhub.io/api/news?id=dce1672e84bd87387a8822ce56919123c3e70b417776bb1c234c336743d0f268",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764666544,
      "headline": "Tougher FDA Rules on Vaccine Approval Might Change the Case for Investing in Moderna (MRNA)",
      "id": 137662591,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna recently faced pressure after the U.S. Food and Drug Administration announced plans to require more rigorous safety and efficacy evidence for vaccine approvals, following reports of child fatalities linked to COVID-19 vaccinations. This regulatory overhaul is expected to increase development hurdles for vaccine makers, posing significant new challenges for Moderna’s ongoing innovation and pipeline expansion. We’ll explore how heightened regulatory scrutiny could shape Moderna’s...",
      "url": "https://finnhub.io/api/news?id=dce1672e84bd87387a8822ce56919123c3e70b417776bb1c234c336743d0f268"
    }
  },
  {
    "ts": null,
    "headline": "Stock market news: Dow, S&P, Nasdaq slip; US big pharma deal with UK, and Bitcoin falters",
    "summary": "December did not start well for the market, with all the major indices in the red. Will the theories urging caution against expecting a Santa Claus rally hold? Well, this is just Day 1, and for some, the Christmas tree decorations are still pending. So let us not entirely give up on the holiday ...",
    "url": "https://finnhub.io/api/news?id=f152b15ceac44f2d3628b99b737c651f98ec1e2f50ec4d45830c4e0ab09222d3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764648180,
      "headline": "Stock market news: Dow, S&P, Nasdaq slip; US big pharma deal with UK, and Bitcoin falters",
      "id": 137658728,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "December did not start well for the market, with all the major indices in the red. Will the theories urging caution against expecting a Santa Claus rally hold? Well, this is just Day 1, and for some, the Christmas tree decorations are still pending. So let us not entirely give up on the holiday ...",
      "url": "https://finnhub.io/api/news?id=f152b15ceac44f2d3628b99b737c651f98ec1e2f50ec4d45830c4e0ab09222d3"
    }
  }
]